Drugs for the Treatment of Respiratory Diseases

Drugs for the Treatment of Respiratory Diseases

ISBN-10:
0521773210
ISBN-13:
9780521773218
Pub. Date:
01/28/2003
Publisher:
Cambridge University Press

Hardcover

Current price is , Original price is $394.0. You
Select a Purchase Option
  • purchase options
    $157.60 $394.00 Save 60% Current price is $157.6, Original price is $394. You Save 60%.
  • purchase options

Overview

Drugs for the Treatment of Respiratory Diseases

Millions of people are affected by these diseases, and the re-emergence of tuberculosis and increase in asthma in certain populations underline the importance of finding effective treatments. The demographice make this a critical time to identify novel strategies to prevent and treat these increasingly common diseases. The volume surveys and evaluates the drug treatments available for the main categories of lung diseases, including asthma, tuberculosis, smoking disorders, lung cancer, and respiratory infections.

Product Details

ISBN-13: 9780521773218
Publisher: Cambridge University Press
Publication date: 01/28/2003
Pages: 612
Product dimensions: 7.44(w) x 9.69(h) x 1.50(d)

Table of Contents

Part I. Asthma and COPD: 1. Pathology of asthma and COPD Peter K. Jeffery; 2. Glucocorticosteroids Peter J. Barnes; 3. ß2- adrenoceptor agonists Domenico Spina, Clive P. Page and Brian J. O'Connor; 4. Anticholinergic bronchodilators Jeremy M. Segal and Nicholas J. Gross; 5. Antiallergic drugs Mazakazu Ichinose; 6. Drugs affecting the synthesis and action of leukotrienes Paul M. O'Byrne; 7. Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease N. A. Jones, Domenico Spina and Clive P. Page; 8. Potential therapeutic effects of potassium channel openers in respiratory diseases Ahmed Z. El-Hashim; 9. Tachykinin and kinin antagonists Pierangelo Geppetti; 10. Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) Lawrence G. Garland and Alan G. Lamont; 11. Drugs targeting cell signalling Brydon L. Bennett, Yoshitaka Satoh and Alan J. Lewis; Part II. Diffuse Parenchymal Lung Disease: 12. Current approaches to the treatment of parenchymal lung diseases Joseph P. Lynch III and Michael Keane; 13. Drug treatments of the future in fibrotic lung disease Athol U. Wells; Part III. Infection: 14. Current and future management of pneumonia Mario Cazzola and Maria G. Matera; 15. Current treatment of chronic bronchial suppuration Robert Wilson; 16. Current and future treatment of cystic fibrosis R. Gary, G. Ruiz, Hilary Wyatt and John F. Price; Part IV. Pulmonary Vascular Diseases: 17. Pathophysiology of pulmonary vascular disease Sanjay Mehta and David G. McCormack; 18. Current treatment of pulmonary vascular diseases Tarek Saba and Andrew Peacock; 19. Future treatment of pulmonary vascular diseases Norbert F. Voelkel, M. W. Geraci and S. Abman; Part V. Lung Cancer:20. Molecular pathology of lung cancer Ignacio I. Wistuba and Adi F. Gazdar; 21. Small cell lung cancer Desmond N. Carney; Part VI. Cough: 22. Mechanisms of cough John J. Adcock; 23. Current treatment of cough Peter V. Dicpinigaitis.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews